In late 2025, Arcturus Therapeutics Holdings Inc. filed an omnibus shelf registration of up to US$500 million, covering ...
This is a summary of: Liu. H. et al. Viral RNA blocks circularization to evade host codon usage control. Nature https://doi.org/10.1038/s41586-025-09809-y (2025).
This innovative company's stock price marched higher today in the FTSE 250 index. Might this be my first Stocks and Shares ...
TipRanks on MSN
PYC Therapeutics issues 2.5 million employee options ahead of key 2026 data milestones
An announcement from PYC Therapeutics Limited ( ($AU:PYC) ) is now available. PYC Therapeutics has granted 2.5 million unlisted options to senior ...
Pharmaceutical Technology on MSN
Eli Lilly acquires inflammatory specialist Ventyx for $1.2bn
The deal marks Lilly’s first in the M&A arena in 2026 as the company diversifies its pipeline beyond obesity drugs.
Gold climbed to a fresh record high on Monday, as a mix of geopolitical tension and questions over Federal Reserve independence sent investors towards safe havens. Gold was quoted at USD4,596.60 an ...
(Alliance News) - Stock prices in London tiptoed into the red by midday on Monday, with the FTSE 100 edging marginally lower as the dollar fell after US prosecutors opened an inquiry threatening a ...
As of Friday, January 09, Capricor Therapeutics, Inc.’s CAPR share price has dipped by 6.99%, which has investors questioning ...
Learn more about whether Twist Bioscience Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics ( NTLA ) ...
Bristol Myers Squibb Company BMY has delivered a solid performance in recent months. The biotech major’s shares have gained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results